Flondell-Sité et al in this issue of Angiology report that besides abdominal aortic aneurysm (AAA) diameter (P ¼ .0019), endothelin-1 (ET-1) levels (P ¼ .0230) were significant predictors of AAA growth in 178 patients with AAA followed conservatively (mean: 2.9 + 1.6 years). 1 In univariate analysis, ET-1 levels also predicted death or need for AAA surgery. 1 These results suggest an alternative/additional predictor of AAA growth and rupture risk besides AAA diameter.
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Currently, the main criterion for AAA repair is an AAA diameter 5.5 cm. 2 The 5.5-cm diameter threshold is the size when the AAA rupture rate balances the mortality rates of elective AAA repair (3%). 2 However, some AAAs rupture when they are smaller and many are discovered after they have exceeded this critical diameter but have not ruptured. 3 It therefore seems that size alone is not sufficient to assess AAA rupture risk. The discovery of alternative predictors of AAA growth and rupture risk holds implications for a more appropriate (earlier/later) surgical management of AAAs.
This Editorial discusses potential predictors of AAA growth and rupture risk besides AAA diameter and ET-1.
i) 18F-fluorodeoxyglucose (FDG) uptake
Metabolic processes, such as chronic inflammation and proteolysis, play a pivotal role in AAA formation and rupture. [4] [5] [6] Increased 18F-FDG metabolism measured by positron emission tomography (PET) computed tomography (CT) scans have been described in aortic infection, arteritis, inflammation, as well as symptomatic AAAs. 7, 8 A recent study demonstrated increased aortic 18F-FDG metabolism in patients with asymptomatic AAAs compared with healthy controls (mean maximum standard uptake values [SUV max ], 3.5 + 0.6 vs 3.0 + 0.5, respectively; P < .05). 9 Furthermore, patients with symptomatic AAAs had significantly higher focal 18F-FDG metabolism compared with individuals with asymptomatic AAAs (mean SUV max , 7.5 + 0.3 vs 3.5 + 0.6, respectively; P < .05). These findings lead the authors to conclude that ''18F-FDG PET CT imaging might be a new approach to identify AAAs at risk before acute aneurysm onset.'' 9 Although promising, these preliminary results need to be validated in appropriately designed trials.
i) Pulse-wave velocity (PWV)
Our group recently investigated the prognostic value of the carotid-femoral aortic PWV (a marker of arterial stiffness and cardiovascular risk and a possible predictor of AAA rupture risk) [10] [11] [12] before and after elective open AAA repair. 13 Patients (n ¼ 24) scheduled for an open AAA repair underwent 2 carotid-femoral aortic PWV measurements; 1 preoperatively and another 6 months later. A polytetrafluoroethylene aortobifurcated graft (aortobi-iliac or aortobi-femoral) was introduced in all patients. Mean aortic PWV increased from 7.84 + 1.85 preoperatively to 10.08 + 1.57 m/s 6 months postoperatively (P < .0001). However, the preprocedural PWV measurement did not correlate with AAA diameter (Spearman rank correlation coefficient r ¼ .12; P ¼ .594). 13 In normal aortas, the propagation of the pulse wave is relatively uniform along the wall. In AAAs, the aortic wall mechanical properties are changed; there is less aortic distensibility and a lower propagation of the aortic pulse pressure (ie, a lower PWV). 14 The uniformity of the propagation of the pulse wave is restored when the AAA is resected and a graft is introduced. This interpretation explains the low PWV values preoperatively and the increased values postoperatively. Aortic PWV may become an adjunct tool for assessing AAA rupture risk, but this concept needs to be verified in larger trials.
i) Statins
Another finding of the study by Flondell-Sité et al is that statin-treated patients showed lower AAA growth after 2 (3.5 + 2.3 vs 5.1 + 6.8 mm, respectively; P ¼ .013) and 4 (5.4 + 3.3 vs 6.5 + 10.4 mm, respectively; P ¼ .04) years of follow-up compared with statin nonusers. 1 Statins were reported to cause regression or slow the progression of AAA growth in other studies. 15, 16 It was thus proposed that statins are an essential component of the management of patients with AAA. 17 Even if statins do not cause regression or slow the progression of AAAs, their use is associated with improved perioperative morbidity and mortality rates. 18 Statins are antiinflammatory and anti-oxidant agents, 19, 20 and this action may play a beneficial role. 21 Another effect of statins is an independent reduction of arterial stiffness. [22] [23] [24] Statins improve endothelial function and increase flow-mediated dilatation. 25 These agents also inhibit the migration of macrophages and smooth muscle cell proliferation, thus stabilizing atherosclerotic plaques. 25 These effects probably contribute to the reduction in AAA expansion rates. 1, 15, 16 Irrespective of all these effects, AAAs are considered coronary heart disease (CHD) equivalents; 26 thus, statin use is virtually mandatory.
Conclusions
Abdominal aortic aneurysm diameter may not be a comprehensive predictor of AAA instability and rupture risk. Other parameters/biomarkers may also play an important role (eg, in inflammatory AAAs). A biomarker able to predict AAA progression should meet 3 criteria: (1) biological plausibility, (2) correlation with AAA progression, and (3) prediction of treatment effect on disease outcome. 27 Circulating levels of several markers of extracellular matrix degeneration with biological plausibility have been correlated with AAA progression, such as elastin peptides, aminoterminal propeptide of type III procollagen, elastase-a1-antitrypsin complexes, matrix metalloproteinase 9, cystatin C, plasmin-antiplasmin complexes, and tissue plasminogen activator. 27 Others supported that a quantitative 3-dimensional tortuosity index of the AAA shape 28 or the peak wall stress and the mean centerline curvature of the AAA 29 may be better predictors of the AAA rupture potential than AAA size. Although promising results have been reported, no definite conclusions can be drawn yet. 27 Future studies are needed to evaluate and identify novel predictors of AAA growth and rupture risk.
